Nathaniel W Snyder

Plain English
This study looked at how the Chameau gene (Chm) affects the body's ability to handle starvation and how this ability changes with temperature. The researchers found that at lower temperatures (23°C), Chm is necessary for survival during starvation, but when the temperature rises by just 2°C, the gene's role becomes less important as the body's metabolism can compensate. This is significant because it highlights how environmental changes, like climate change, can impact how genes function in different situations and affect survival. Who this helps: This helps scientists and researchers studying metabolism and survival in changing climates.

Plain English
This research studied a specific protein modification called lysine L-lactylation, which is influenced by the process of glycolysis. The findings showed that lysine L-lactylation is the main form of this modification in histones, while other forms were less significant when glycolysis is functioning properly. Understanding this process is important because it sheds light on how certain changes in cells are tied to conditions like cancer, where glycolysis is often altered. Who this helps: This helps researchers and doctors studying cancer and metabolic diseases.

Plain English
This study looked at how zinc levels in tumors affect the effectiveness of anti-PD1 therapy, especially in tumors that have many immune cells called macrophages but few T cells. The researchers found that tumors often limit zinc availability, which makes macrophages less effective at fighting cancer. When zinc levels were restored in these macrophages, they were better able to help the anti-PD1 treatment work, particularly in mice lacking T cells. This is important because it reveals a new way to potentially improve cancer treatment by focusing not just on T cells, but also on the role of macrophages and zinc. Who this helps: This helps cancer patients, especially those with T cell-poor tumors.

Plain English
This study focused on how certain enzymes, known as class I histone deacetylases (specifically HDACs 1, 2, and 3), help create a protein modification called lysine lactylation (Kla) from lactate. Researchers found that these HDACs are responsible for most of the Kla formation in cells, which they confirmed by various laboratory methods. This discovery is significant because it shows a new role for HDACs beyond their traditional functions, potentially impacting how we understand cell metabolism and protein regulation. Who this helps: This research benefits scientists and medical researchers studying metabolic diseases and cellular processes.

Plain English
This study created a new mouse model that mimics high testosterone levels specifically from the ovaries, instead of using external sources of testosterone. The researchers found that these mice had higher testosterone levels and experienced issues like fewer, smaller litters and longer reproductive cycles, but they didn’t gain weight or have metabolic problems. This is important because it helps us understand how excess testosterone from the ovaries affects fertility without influencing other body functions. Who this helps: This research aids scientists and doctors studying women’s reproductive health issues linked to high testosterone.

Plain English
This study looked at how a protein called ATR influences another protein complex known as mTORC1 in both cancer cells and normal human and mouse cells. The researchers found that ATR boosts mTORC1 activity by increasing cholesterol production through a specific process, especially when certain cell cycle inhibitors are absent. This is important because understanding how these proteins interact could lead to better treatments for cancer by targeting metabolic pathways. Who this helps: This helps patients with cancer by potentially leading to new therapies that inhibit cancer growth.

Plain English
This study looked at how specific proteins called MICUs help manage the way cells produce energy in the mitochondria, which are the powerhouses of the cell. Researchers found that these MICU proteins can create specialized structures that link various proteins involved in energy production, affecting their activity based on calcium levels. They showed that this process occurs even without the typical calcium transport channel, suggesting that MICUs play a crucial role in adjusting energy production to meet the cell's needs. Who this helps: This research benefits patients with metabolic disorders and doctors who treat them.

Plain English
This study focused on how a group of enzymes called class I histone deacetylases (HDACs) can create a modification on proteins known as lysine lactylation (Kla). The researchers found that these HDACs are key players in making Kla, regardless of the levels of another molecule called lactyl-CoA in cells. This discovery is important because it sheds light on how cells can regulate protein function through metabolism, which can have implications for understanding various diseases. Who this helps: This helps researchers and doctors working on metabolic diseases and cancer therapies.

Plain English
This study looked at how the levels of a substance called NAD in liver cells (hepatocytes) affect the liver's ability to regenerate. The researchers found that higher levels of NAD in the mitochondria of liver cells lead to faster liver regeneration. Specifically, tweaking the levels of a protein named SLC25A51 that controls NAD transport can either decrease or increase NAD levels and impact liver recovery; enhancing SLC25A51 led to better regeneration, similar to taking NAD supplements. Who this helps: This research benefits patients recovering from liver disease or injury.

Plain English
This study focused on creating stable versions of a fatty acid called phytanic acid, which is important for understanding how our bodies break down certain fats. Researchers developed a new method to produce these labeled versions, making it easier to track how phytanic acid is processed in the body, specifically through different metabolic pathways. This work is significant because it helps researchers study conditions, like Refsum Disease, where this breakdown process is impaired. Who this helps: This benefits researchers and doctors studying metabolic disorders related to fatty acids.

Plain English
This study examined the effects of bempedoic acid (BPA) on fat buildup in the liver, particularly looking at how it interacts with a protein called ATP-citrate lyase (ACLY). Researchers found that even when ACLY is not functioning, BPA still reduces fat accumulation in the liver caused by a high-fat Western diet. This is significant because it shows that BPA can improve liver health by lowering fat levels without directly targeting ACLY. Who this helps: This benefits patients with conditions like fatty liver disease.

Plain English
This study focused on how the breakdown of branched-chain amino acids, particularly isoleucine, affects gene activity in pancreatic cancer cells. The researchers found that limiting isoleucine reduces a chemical modification on proteins (known as histone propionylation) that is linked to cancer growth, specifically leading to decreased expression of certain genes involved in lipid metabolism and immune response. This is important because it reveals a new metabolic pathway in pancreatic cancer that could be targeted for treatment. Who this helps: This helps patients with pancreatic cancer by identifying potential new treatment strategies.

Plain English
This study looked at how certain amino acids in the body affect the development of pancreatic cancer. Researchers found that losing a specific protein (DBT) in the pancreas made precancerous conditions worse in mice, while blocking a different protein (BCKDK) throughout the body helped reduce these precancerous conditions. This suggests that promoting amino acid breakdown outside the pancreas could be a useful approach for preventing pancreatic cancer. Who this helps: This benefits patients at risk for pancreatic cancer.

Plain English
This research paper studied the effects of losing an enzyme called succinate dehydrogenase (SDH) in cancer. When SDH is absent, it disrupts the body's usual metabolism, making cancer cells vulnerable to certain treatments. The authors highlight that SDH loss is linked to various cancers, such as pheochromocytomas and clear cell renal cell carcinomas, showing a need for new targeted therapies that could help treat these conditions. Who this helps: This helps patients with specific cancers related to SDH loss and their doctors seeking effective treatments.

Plain English
This study examined how a protein called PSAT1, which is crucial for heart development, affects heart repair after a heart attack (myocardial infarction) in mice. Researchers found that delivering a modified version of PSAT1 directly to the hearts of mice after a heart attack increased the number of heart cells, reduced scar tissue, and improved heart function, showing a significant enhancement in heart performance (exact numbers were not specified). This is important because it suggests that targeting PSAT1 could lead to new treatments that help the heart recover better after serious damage. Who this helps: This research benefits patients recovering from heart attacks.

Plain English
This study looked at how a group of signals from aging cells, triggered by chemotherapy, helps ovarian cancer cells spread to other parts of the body. The researchers found that when ovarian cancer cells were treated with cisplatin (a common chemotherapy drug), they released factors that promoted the detachment of nearby cancer cells, leading to increased spread. Specifically, they discovered that a metabolic process involving fructose and cholesterol plays a key role in this, and a high-fructose diet can further increase the cancer's spread. Who this helps: This research benefits patients with high-grade serous ovarian cancer by highlighting factors that could influence their treatment and recurrence rates.

Plain English
This study focused on how a specific type of KRAS mutation, called KRAS G12V, affects cell metabolism in colorectal cancer. Researchers discovered that cells with this mutation rely heavily on a protein called ACSS2 for growth, making them more vulnerable to certain treatments when ACSS2 is blocked. They found that targeting ACSS2 could help improve treatment effectiveness for patients with this mutation, which is important because different mutations can respond differently to therapies. Who this helps: This research benefits patients with KRAS G12V colorectal cancer.

Plain English
This research studied how a protein called ATR influences another protein group known as mTORC1, which is involved in cell growth and metabolism. The scientists found that ATR promotes mTORC1 activity by increasing cholesterol production, especially in certain cells that have lost a protein called p16. This is important because it highlights a new way that cells manage their growth and response to damage, which could help develop targeted therapies for diseases like cancer. Who this helps: Patients with cancer or other conditions related to cell growth and metabolism.

Plain English
This study examined different methods for measuring a substance called acetyl-Coenzyme A (acetyl-CoA), which plays an important role in metabolism. The researchers found that a colorimetric test did not provide useful results, while a fluorometric test gave results that were similar to a more advanced technique called liquid chromatography-mass spectrometry (LC-MS). This matters because having reliable ways to measure acetyl-CoA can help researchers understand changes in metabolism that are important for diseases like cancer. Who this helps: This benefits researchers and doctors working on metabolic diseases and cancer.

Plain English
This study looked at a compound called lactoylglutathione (LGSH) and its role in inflammation within immune cells known as macrophages. Researchers found that when they reduced an enzyme that normally breaks down LGSH, the levels of LGSH increased, leading to stronger inflammatory signals in the macrophages after exposure to a specific bacterial component, resulting in over a 50% increase in inflammatory response markers. This matters because understanding how LGSH influences inflammation can help in developing treatments for chronic metabolic disorders linked to persistent inflammation. Who this helps: This helps patients with metabolic disorders and chronic inflammation.

Plain English
This study looked at how a metabolic enzyme called ACSS2 affects ovarian cancer cells when they become inactive, or quiescent. Researchers found that when these cells are in a quiescent state, they produce more of a molecule called acetyl-CoA from acetate, which helps them survive. In lab tests, increasing ACSS2 levels or adding acetate led to more cells entering this inactive state, and in patients, higher ACSS2 levels in tumor cells were linked to worse outcomes and resistance to chemotherapy. Who this helps: This benefits ovarian cancer patients and their doctors by highlighting a potential challenge in treatment strategies.

Plain English
This study looked at how a specific enzyme called ACSS2 helps ovarian cancer cells survive when they stop growing, a state known as quiescence. Researchers found that quiescent ovarian cancer cells have higher levels of a compound called acetyl-CoA produced from acetate, and that manipulating ACSS2 or adding acetate could trigger cells to enter this quiescent state. Notably, high levels of ACSS2 were linked to chemotherapy resistance and poorer patient outcomes. Who this helps: This research helps patients with ovarian cancer and their doctors by highlighting a potential reason for treatment resistance.

Plain English
Researchers studied how meconium, the first stool of newborns, relates to hormone exposure in the womb, specifically focusing on testosterone and a hormone called DHEA. They found that testosterone levels in meconium were linked to higher testosterone levels in infants at 1 and 4 weeks old, with statistical evidence supporting this connection (F=5.62, p=0.029 and F=4.28, p=0.048). Understanding these hormone levels is important because it can help assess fetal development and hormone exposure, which may impact health later in life. Who this helps: This benefits healthcare providers and researchers studying prenatal development and hormone-related health issues in infants.

Plain English
This study looked at a protein called ATP-citrate lyase (ACLY) in brown fat tissue, which helps regulate how the body burns energy. Researchers found that when mice were fed a diet high in carbohydrates, ACLY helps brown fat produce heat and avoid metabolic stress; without ACLY, the fat couldn't function properly, leading to increased stress and less heat production. This is important because it shows how the availability of carbohydrates affects our ability to burn fat and maintain energy balance. Who this helps: This benefits patients struggling with obesity or metabolic disorders.

Plain English
This study looked at how glioblastoma, a deadly type of brain cancer, uses a substance called lactate to protect itself from the immune system. Researchers found that lactate from cancer cells and immune cells triggers changes in tumor cells that help them escape attack by the immune system, specifically by increasing a "don't eat me" signal called CD47. They also discovered that blocking lactate production can make anti-CD47 treatments more effective, leading to decreased tumor growth and improved immune response. Who this helps: This helps patients with glioblastoma by potentially improving treatment options.

Plain English
This study looked at how a compound called alpha-ketoglutarate (αKG) affects the ability of certain cancer cells to repair their DNA after being damaged by treatment. Researchers found that when αKG is reduced, it makes these cancer cells more sensitive to DNA damage. Specifically, they discovered that a key enzyme related to carnitine production is essential for the cancer cells to survive this damage, indicating that boosting histone acetylation through carnitine synthesis can enhance DNA repair in cancer cells. Who this helps: This benefits cancer patients, particularly those with tumors that are proficient at repairing DNA.

Plain English
This study looked at how a specific peptide, FhHDM-1, can change immune cells (macrophages) that are involved in type 1 diabetes. The researchers found that treating these immune cells from mice with type 1 diabetes lowered their inflammatory responses and brought them back to a healthier state, similar to those in non-diabetic mice. This is important because it suggests a way to lessen the harmful immune responses associated with type 1 diabetes. Who this helps: This benefits patients with type 1 diabetes by potentially providing a new treatment option.

Plain English
This study focused on a protein called p16 that helps prevent cancer, which is often missing in about 50% of cancers. Researchers found that cancer cells lacking p16 are more vulnerable to specific drugs that block a process called de novo purine synthesis, with some treatments resulting in better responses in tumors without p16. In tests, tumors without p16 responded well to the drug methotrexate, showing a potential new way to use existing treatments effectively for these cancers. Who this helps: Patients with low p16 expression tumors may benefit from targeted therapies.

Plain English
This study looked at how a protein called GLUT5 can improve the function of CAR-T cells, a type of immune cell used to fight cancer. Researchers found that when they increased GLUT5 in CAR-T cells, those cells performed better in environments with high levels of fructose, like those found in patients with acute myeloid leukemia (AML). Specifically, GLUT5 helped these cells move faster and become more effective at killing cancer cells, leading to better overall cancer-fighting ability. Who this helps: This benefits cancer patients, particularly those with AML, by potentially improving the effectiveness of CAR-T cell therapies.

Plain English
Researchers studied two promising drugs, AD-5584 and AD-8007, that target a specific enzyme (ACSS2) in breast cancer cells that spread to the brain. They found that these drugs significantly reduced cancer cell growth and survival, with AD-8007 also decreasing tumors and extending survival in treated models. This is important because it offers a new treatment option for a type of breast cancer that is difficult to manage when it spreads to the brain. Who this helps: This helps patients with breast cancer that has spread to the brain.

Plain English
Researchers studied how different mutations in the KRAS gene affect the formation of colorectal cancer by creating mouse colon cells with specific changes to this gene. They found that the G12V mutation leads to higher activity in certain pathways related to cholesterol and fats, and that blocking a protein called ACSS2 made the G12V cells more sensitive to treatment. This matters because understanding these differences can help develop better treatments for patients with specific KRAS mutations in colorectal cancer. Who this helps: This helps patients with colorectal cancer, especially those with specific KRAS mutations.

Plain English
This study examined how a substance called acetylcarnitine helps cells produce a vital compound called acetyl-CoA, which is important for making fats and modifying proteins that control gene activity. The researchers found that even without two main pathways for creating acetyl-CoA, cancer cells can still generate it from glucose and fats, relying on acetylcarnitine to do so. Specifically, they discovered that this process allows cells to continue growing and synthesizing fats effectively, even when other pathways are shut down. Who this helps: This research aids cancer patients and doctors by providing insights on potential metabolic pathways to target in treatment.

Plain English
The study looked at the role of a specific enzyme called Acyl-CoA thioesterase 12 (Acot12) in liver cancer development in mice. Researchers found that mice lacking this enzyme developed liver tumors faster and had higher levels of certain fat molecules (glycerolipids), which led to increased activity of a cancer-related protein called YAP. This matters because enhancing what Acot12 does could help prevent liver cancer by controlling fat production in the liver. Who this helps: This helps patients at risk for liver cancer.

Plain English
This study focused on a compound called itaconic acid and its role in fat metabolism in the liver, specifically in a type of liver disease known as non-alcoholic fatty liver disease (NAFLD). Researchers found that male mice lacking the gene needed to produce itaconic acid had more fat stored in their livers and issues with processing sugar and insulin. When these mice were treated with a form of itaconic acid, called 4-octyl itaconate, their fat levels decreased, suggesting that itaconic acid helps the liver manage fats better. Who this helps: This research can benefit patients with non-alcoholic fatty liver disease and their doctors.

Plain English
This study looked at a process called endothelial-to-mesenchymal transition (EndMT), which contributes to chronic blood vessel diseases. The researchers discovered that a substance called acetate, produced from glucose, plays a key role in keeping this process going by increasing certain signals in the body. They found that when EndMT is activated, it reduces a specific enzyme and leads to changes that reinforce the EndMT process, highlighting new targets for treating vascular diseases. Who this helps: This helps patients with chronic vascular diseases.

Plain English
This study compared different methods for measuring acetyl-Coenzyme A (Acetyl-CoA), an important molecule in metabolism. The researchers found that while a colorimetric kit was unreliable, a fluorometric kit gave results similar to advanced liquid chromatography-mass spectrometry (LC-MS) techniques. Specifically, the LC-MS methods showed accurate and consistent results, especially when internal standards were used, making them a better option for researchers. Who this helps: This benefits researchers studying metabolism and diseases like acute myeloid leukemia.

Plain English
This study investigated how a protein called ACOT2 affects fat breakdown in muscle cells, especially when there are different amounts of fats available. The researchers found that when ACOT2 was removed in mice’s muscle tissue, fat levels increased when moderate amounts of fat were present, but the cells switched to using more sugar for energy instead. This change was linked to worse blood sugar control when the mice were on a high-fat diet, highlighting ACOT2's role in maintaining a balance between using fats and sugars for energy based on available nutrients. Who this helps: This research benefits patients and doctors dealing with metabolic disorders and obesity.

Plain English
This study focused on creating a new way to selectively detect a molecule called acetyl-CoA, which is important for many biological processes. Researchers discovered that a specific protein, NAA50, can effectively tell the difference between acetyl-CoA and a related molecule, CoA. By using this protein in a special setup, they were able to not only detect acetyl-CoA in cell samples but also quantify its levels accurately. Who this helps: This helps researchers and scientists who need precise measurements of acetyl-CoA in their studies.

Plain English
This study looked at a protein called p16, which helps control cell growth, and how its loss affects cancer cells, particularly in melanoma. Researchers found that when p16 is missing in these cancer cells, they rely more on certain pathways for making building blocks of DNA and RNA, making them vulnerable. Specifically, tumors with low p16 levels were found to be more sensitive to a drug called methotrexate than others, suggesting that this drug might be particularly effective against these tumors. Who this helps: This information can benefit patients with tumors low in p16 and their doctors in choosing treatment options.

Plain English
This study looked at how stress within cells (specifically in the endoplasmic reticulum) affects the body's immune response and the development of aneurysms in different parts of the aorta (the large artery in the body). The researchers found that the abdominal aorta had a stronger inflammatory response and unique genetic changes compared to the thoracic aorta when exposed to angiotensin II, a hormone linked to high blood pressure; specifically, 890 genes were more active in the abdominal aorta. This is important because it helps explain why aneurysms develop differently depending on the location in the body, which could lead to better prevention and treatment strategies. Who this helps: This helps patients at risk for aortic aneurysms and doctors treating them.

Plain English
Researchers studied how pancreatic cancer cells interact with nearby cells called cancer-associated fibroblasts (CAFs), which help the cancer grow and avoid the immune system. They discovered that CAFs transfer important lipids, like cholesterol, to pancreatic cancer cells using a process called trogocytosis, and that this process is controlled by a protein called ANO6. By blocking ANO6, they found that tumor growth slowed down and the immune system was better able to fight the cancer. Who this helps: This research helps patients with pancreatic cancer by identifying a new potential treatment target.

Plain English
This study looked at how brown fat cells in the body adapt after being exposed to cold temperatures. Researchers found that just one cold exposure helps these fat cells remember how to burn more energy when faced with cold again, improving their response by up to 30%. This is important because it could lead to new ways to use short-term cold exposure to help manage obesity. Who this helps: Patients looking to lose weight or manage obesity.

Plain English
This study focused on how high levels of homocysteine—a building block in the body—affect the ability of brain immune cells, called microglia, to clear amyloid-beta (Aβ), a substance that accumulates in Alzheimer's disease. The researchers found that 353 genes in the microglia were altered due to high homocysteine levels, leading to reduced clearance of Aβ. Specifically, they identified 5 genes that may hinder the microglia's ability to fight against Alzheimer's, highlighting how changes in gene expression related to low-level DNA modifications may play a role in the disease. Who this helps: This research benefits patients with Alzheimer's disease and their caregivers by providing insights into potential new treatment strategies.

Plain English
This study focused on a molecule called lactoylglutathione (LGSH) and its role in inflammation, specifically in certain immune cells called macrophages. Researchers found that when a key enzyme responsible for breaking down LGSH was not present, levels of LGSH increased significantly, causing a heightened inflammatory response when exposed to certain triggers. This is important because it shows that LGSH is a major player in how the body responds to inflammation, which can be linked to various metabolic disorders. Who this helps: This helps patients with inflammatory conditions and doctors treating metabolic disorders.

Plain English
This study looked at how a diet low in branched-chain amino acids (BCAAs) affects heart health, particularly in mice with heart failure. Researchers found that this diet helps protect the heart by influencing certain chemical signals that control heart stress responses, linked to a specific change in a protein called histone. The results highlight that modifying diet can play a significant role in reducing heart muscle thickening, which is a major problem in heart disease. Who this helps: This helps patients with heart failure by suggesting dietary changes that may improve their condition.

Plain English
This study looked at how propionyl-CoA, a compound linked to certain metabolic disorders, affects gene expression in the hearts of mice with a condition called propionic acidemia. Researchers found that problems with propionyl-CoA lead to changes in the way genes are activated in the heart, potentially harming heart function. Understanding this connection is important because it may help identify new ways to treat heart problems in people with metabolic disorders. Who this helps: Patients with metabolic disorders affecting heart health.

Plain English
This study looked at how cells can use proteins to help generate energy when nutrients are low, specifically focusing on a process called deacetylation, where acetyl groups are removed from proteins. Researchers found that while this process does provide some carbon for energy production (less than 10% of what cells need), it isn't enough to meet the entire energy demand, especially when nutrients are scarce. This matter because understanding how cells manage energy can lead to better strategies for addressing metabolic disorders. Who this helps: This helps patients with metabolic disorders and their doctors.

Plain English
This study looked at how glioblastoma stem cells (GSCs), which are a type of brain cancer cell, process lysine, an amino acid. Researchers found that altering the way GSCs handle lysine led to changes in the tumor environment that could help the tumor grow. Specifically, they saw that reducing a certain type of lysine modification slowed down tumor growth and increased immune cell activity against the tumor; for instance, treating mice with both a lysine-restricted diet and another therapy significantly slowed tumor growth compared to either treatment alone. Who this helps: This research benefits cancer patients, particularly those with glioblastoma, by suggesting new dietary and treatment strategies to fight tumors.